Alcon 

€59.68
262
+€1.12+1.91% Wednesday 19:56

Statistics

Day High
60.06
Day Low
58.44
52W High
87.04
52W Low
54.41
Volume
-
Avg. Volume
-
Mkt Cap
29.11B
P/E Ratio
99.97
Dividend Yield
0.51%
Dividend
0.31

Upcoming

Dividends

0.51%Dividend Yield
May 26
€0.31
May 25
€0.30
May 24
€0.24
May 23
€0.21
May 22
€0.19
10Y Growth
N/A
5Y Growth
27.28%
3Y Growth
12.46%
1Y Growth
2.56%

Earnings

10AugExpected
Q1 2026
Next
0.65
0.67
0.69
0.71
Expected EPS
0.6500219133186199
Actual EPS
N/A

Financials

9.42%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
8.85BRevenue
833.19MNet Income

Analyst Ratings

64.28Average Price Target
The highest estimate is 72.09.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
71%
Hold
29%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2U3.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, competes in the eye health market, particularly in areas like contact lenses and surgical products similar to Alcon's offerings.
Cooper Companies
COO
Mkt Cap13.79B
The Cooper Companies operate through CooperVision and CooperSurgical, offering products that directly compete with Alcon's contact lens and eye care solutions.
Bausch Health Companies
BHC
Mkt Cap1.79B
Bausch Health Companies, through its division Bausch + Lomb, is a direct competitor in the eye health sector, offering a wide range of products from contact lenses to surgical instruments.
Novartis
NVS
Mkt Cap293.94B
Novartis, the former parent company of Alcon, continues to compete in the eye care market through its pharmaceutical products that address conditions like dry eye, retinal issues, and glaucoma.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie, through its acquisition of Allergan, competes in the eye care market with products targeting conditions such as dry eye and glaucoma, directly competing with Alcon's portfolio.
Staar Surgical
STAA
Mkt Cap1.38B
STAAR Surgical specializes in ophthalmic products, particularly in implantable lenses for the eye, competing directly with Alcon's intraocular lenses and cataract surgery products.
Integra Lifesciences
IART
Mkt Cap1.41B
Integra LifeSciences, while broader in focus, competes with Alcon in the surgical instruments market, particularly in tools and devices used in ophthalmic surgery.
Eco Science Solutions
ESSI
Mkt Cap26,479
EssilorLuxottica is a leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, competing with Alcon's vision care products.

About

Alcon Inc. is a global leader in eye care, engaging in the comprehensive lifecycle of ophthalmic solutions, from initial research and development to manufacturing, distribution, and worldwide sales. Its diverse portfolio serves both eye care professionals and the patients they treat across the globe. The company's operations are divided into two main segments: 1. Surgical Segment: This division provides a vast array of products crucial for ophthalmic surgical procedures. Offerings encompass advanced equipment, sophisticated diagnostic tools, and implantable devices such as intraocular lenses (IOLs). It also supplies essential consumables, including viscoelastics, specialized surgical solutions, incisional instruments, and custom surgical procedure packs. Key product areas within this segment feature: Cataract Management: Technologies like the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and the ORA system for intra-operative measurements, along with custom pak surgical procedure kits. Vitreoretinal Interventions: Including Constellation Vision Systems, procedure packs, lasers, hand-held microsurgical instruments (such as grieshaber and MIVS), a range of scissors, forceps, micro-instruments, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive Correction: WaveLight lasers and Contoura Vision, specifically utilized for LASIK treatments. Glaucoma Solutions: The EX-PRESS glaucoma filtration device. Advanced Implantables: Such as AcrySof IQ IOLs, which include both monofocal IOLs and cutting-edge technology IOLs marketed under the PanOptix and ReSTOR brands, designed to correct presbyopia and astigmatism during cataract surgery. 2. Vision Care Segment: This segment delivers products aimed at daily vision needs and overall ocular health. Its offerings include daily disposable, reusable, and color-enhancing contact lenses. Furthermore, it provides a variety of eye health products addressing issues like dry eye, glaucoma, contact lens maintenance, and ocular allergies, alongside eye vitamins and redness relievers. These are available under prominent brands such as TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Established in 1945, Alcon Inc. changed its name from Alcon Universal S.A. to its current designation in December 2001. The company's corporate headquarters are located in Geneva, Switzerland.
Show more...
CEO
Mr. F. Michael Ball
Employees
23000
Country
Switzerland
ISIN
CH0432492467

Listings

0 Comments

Share your thoughts

FAQ

What is Alcon stock price today?
The current price of 2U3.STU is €59.68 EUR — it has increased by +1.91% in the past 24 hours. Watch Alcon stock price performance more closely on the chart.
What is Alcon stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Alcon stocks are traded under the ticker 2U3.STU.
Is Alcon stock price growing?
2U3.STU stock has risen by +1.81% compared to the previous week, the month change is a +5.14% rise, over the last year Alcon has showed a -19.15% decrease.
What is Alcon market cap?
Today Alcon has the market capitalization of 29.11B
When is the next Alcon earnings date?
Alcon is going to release the next earnings report on August 10, 2026.
What were Alcon earnings last quarter?
2U3.STU earnings for the last quarter are 0.71 EUR per share, whereas the estimation was 0.68 EUR resulting in a +4.1% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Alcon revenue for the last year?
Alcon revenue for the last year amounts to 8.85B EUR.
What is Alcon net income for the last year?
2U3.STU net income for the last year is 833.19M EUR.
Does Alcon pay dividends?
Yes, 2U3.STU dividends are paid annual. The last dividend per share was 0.31 EUR. As of today, Dividend Yield (FWD)% is 0.51%.
How many employees does Alcon have?
As of July 16, 2026, the company has 23,000 employees.
In which sector is Alcon located?
Alcon operates in the Health & Wellness sector.
When did Alcon complete a stock split?
Alcon has not had any recent stock splits.
Where is Alcon headquartered?
Alcon is headquartered in Geneva, Switzerland.